Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial

OBJECTIVES: 1. To assess the efficacy of Mesenchymal Stromal Cells (MSC) versus a control arm as described in the primary endpoint. 2. To evaluate the effects of MSC on the secondary efficacy endpoints. 3. To evaluate the safety and tolerability profiles of MSC. 4. To study soluble and cellular biom...

Descripción completa

Detalles Bibliográficos
Autores principales: Payares-Herrera, Concepción, Martínez-Muñoz, María E., Vallhonrat, Inés Lipperheide, de Molina, Rosa Malo, Torres, Manuel Pérez, Trisan, Andrea, de Diego, Isabel Salcedo, Alonso, Rosalía, Zafra, Rocío, Donaire, Trinidad, Sánchez, Rocío, Rubio, Juan José, Duarte Palomino, Rafael F., Solá, Cristina Avendaño
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785778/
https://www.ncbi.nlm.nih.gov/pubmed/33407777
http://dx.doi.org/10.1186/s13063-020-04964-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785778/
https://www.ncbi.nlm.nih.gov/pubmed/33407777
http://dx.doi.org/10.1186/s13063-020-04964-1

Ejemplares similares